| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;109:473-485
© 1995 Mosby, Inc.
GENERAL THORACIC SURGERY |
Boston, Mass., Durham, N.C., Syracuse, N.Y., Baltimore, Md., San Diego, Calif., and Lebanon, N.H.
New York, N.Y.
From the Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Mass.; the Division of Biometry and Medical Informatics, Department of Community and Family Medicine and CALGB Statistical Center, Duke University Medical Center, Durham, N.C.; the Department of Surgery, SUNY Health Science Center, State University of New York, Syracuse, N.Y.; The Department of Surgery, University of Maryland Cancer Center, University of Maryland School of Medicine, Baltimore, Md.; and the Department of Hematology/Oncology, University of California San Diego Medical Center, San Diego, Calif.
Address for reprints: David J. Sugarbaker, MD, Division of Thoracic Surgery, Brigham & Women's Hospital, 75 Francis St., Boston, MA 02115.
Abstract
From October 1989 to February 1992, 74 patients with mediastinoscopically staged IIIA (N2) non-small-cell lung cancer from 30 CALGB-affiliated hospitals received two cycles of preresectional cisplatin and vinblastine chemotherapy. Patients with responsive or stable disease underwent standardized surgical resection and radical lymphadenectomy. Patients who underwent resection received sequential adjuvant therapy with two cycles of cisplatin and vinblastine, followed by thoracic irradiation (54 Gy after complete resection and 59.4 Gy after incomplete resection or no resection at 1.8 Gy per fraction). There were no radiographic complete responses to the neoadjuvant chemotherapy, although 65 (88%) patients had either a response or no disease progression. During induction chemotherapy, disease progressed in seven patients (9%). Sixty-three patients (86%) had exploratory thoracotomy, and 46 of those (75%) had resectable lesions. A complete surgical resection was accomplished in 23 patients, and 23 patients had an incomplete resection with either a diseased margin or diseased highest node resected. Operative mortality was 3.2% (2/63). In 10 patients (22% of the 46 having resection) the disease was pathologically downstaged. There was no correlation between radiographic response to the induction chemotherapy and downstaging at surgical resection. The full protocol was completed by 33 patients (45% of original cohort). Overall survival at 3 years was 23%. Patients undergoing resection had significantly improved survival at 3 years compared with patients not having resection: 46% for complete resection (median 20.9 months), 25% for incomplete resection (median 17.8 months), and 0% for no resection (median 8.5 months). Five deaths occurred during the treatment period. A total of 18 of the 46 (39%) patients who underwent resection are either alive and disease-free or have died without recurrence. (J THORAC CARDIOVASC SURG 1995; 109: 473-85)
This article has been cited by other articles:
|
|
 |
|
  P. Garrido, J. L. Gonzalez-Larriba, A. Insa, M. Provencio, A. Torres, D. Isla, J. M. Sanchez, F. Cardenal, M. Domine, J. R. Barcelo, et al. Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901 J. Clin. Oncol., October 20, 2007; 25(30): 4736 - 4742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Leo, T. De Pas, G. Catalano, G. Piperno, G. Curigliano, P. Solli, G. Veronesi, F. Petrella, and L. Spaggiari Re: Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non Small-Cell Lung Cancer J Natl Cancer Inst, August 1, 2007; 99(15): 1210 - 1210. [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Meerbeeck, G. W. P. M. Kramer, P. E. Y. Van Schil, C. Legrand, E. F. Smit, F. Schramel, V. C. Tjan-Heijnen, B. Biesma, C. Debruyne, N. van Zandwijk, et al. Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer J Natl Cancer Inst, March 21, 2007; 99(6): 442 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Takeda, H. Maeda, T. Okada, T. Yamaguchi, M. Nakagawa, S. Yokota, N. Sawabata, and M. Ohta Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Kohman Cancer and leukemia group B surgery committee. Clin. Cancer Res., June 1, 2006; 12(11): 3622s - 3627s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bernasconi, P. N. Chhajed, F. Gambazzi, L. Bubendorf, H. Rasch, S. Kneifel, and M. Tamm Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC Eur. Respir. J., May 1, 2006; 27(5): 889 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Galetta, A. Cesario, S. Margaritora, V. Porziella, A. Piraino, R. M. D'Angelillo, M. A. Gambacorta, S. Ramella, L. Trodella, S. Valente, et al. Multimodality treatment of unresectable stage III non-small cell lung cancer: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Hennessy, G. N. Hortobagyi, R. Rouzier, H. Kuerer, N. Sneige, A. U. Buzdar, S. W. Kau, B. Fornage, A. Sahin, K. Broglio, et al. Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy J. Clin. Oncol., December 20, 2005; 23(36): 9304 - 9311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsubara, S.-i. Takeda, and T. Mashimo Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection Chest, November 1, 2005; 128(5): 3519 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio, A. S. Bryant, S. A. Spencer, and A. A. Bartolucci Pulmonary Resection After High-Dose and Low-Dose Chest Irradiation Ann. Thorac. Surg., October 1, 2005; 80(4): 1224 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Burfeind Jr, T. A. D'Amico, E. M. Toloza, W. G. Wolfe, and D. H. Harpole Low Morbidity and Mortality for Bronchoplastic Procedures With and Without Induction Therapy Ann. Thorac. Surg., August 1, 2005; 80(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doddoli, F. Barlesi, D. Trousse, S. Robitail, S. Yena, P. Astoul, R. Giudicelli, P. Fuentes, and P. Thomas One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 416 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. DeCamp Jr., S. Ashiku, and R. Thurer The Role of Surgery in N2 Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 5033s - 5037s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Port, R. J. Korst, P. C. Lee, M. A. Levin, D. E. Becker, R. Keresztes, and N. K. Altorki Surgical Resection for Residual N2 Disease After Induction Chemotherapy Ann. Thorac. Surg., May 1, 2005; 79(5): 1686 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ohta, H. Hirabayasi, H. Shiono, M. Minami, H. Maeda, H. Takano, S. Miyoshi, and H. Matsuda Surgical resection for lung cancer with infiltration of the thoracic aorta J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 804 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann. Onc., November 1, 2004; 15(11): 1645 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Sonett, M. Suntharalingam, M. J. Edelman, A. B. Patel, Z. Gamliel, A. Doyle, P. Hausner, and M. Krasna Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non-Small-Cell Lung Cancer Ann. Thorac. Surg., October 1, 2004; 78(4): 1200 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Lynch, C. D. Wright, N. C. Choi, S. L. Aquino, and E. J. Mark Case 26-2004 - A 56-Year-Old Woman with Cough and a Lung Nodule N. Engl. J. Med., August 19, 2004; 351(8): 809 - 817. [Full Text] [PDF]
|
|
|
|
|
|
L. Trodella, P. Granone, S. Valente, S. Margaritora, G. Macis, A. Cesario, R. M. D'Angelillo, V. Valentini, G. M. Corbo, V. Porziella, et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging Ann. Onc., March 1, 2004; 15(3): 389 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. V. Scagliotti and A. T. Turrisi III Docetaxel-Based Combined-Modality Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer Oncologist, August 1, 2003; 8(4): 361 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. DeCamp, T. W. Rice, D. J. Adelstein, M. A. Chidel, L. A. Rybicki, S. C. Murthy, and E. H. Blackstone Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Betticher, S.-F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel, R. A. Schmid, M. Pless, J. Habicht, A. D. Roth, et al. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial J. Clin. Oncol., May 1, 2003; 21(9): 1752 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Choi, Y. M. Shim, J. Kim, and K. Kim Mediastinoscopy in patients with clinical stage I non-small cell lung cancer Ann. Thorac. Surg., February 1, 2003; 75(2): 364 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, T. Koike, and H. Kato A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ohta, N. Sawabata, H. Maeda, and H. Matsuda Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 96 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.G. Spiro Surgery for nonsmall cell lung cancer: can improvements be made? Eur. Respir. J., January 1, 2003; 21(39_suppl): 52S - 56s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Choi, Y. M. Shim, J. Kim, and K. Kim Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 695 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Spiro and J. C. Porter Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cyjon, M. Nili, G. Fink, M. R. Kramer, E. Fenig, J. Sandbank, A. Sulkes, and E. Rakowsky Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation Ann. Thorac. Surg., August 1, 2002; 74(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martin, R. J. Ginsberg, E. S. Venkatraman, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch Long-Term Results of Combined-Modality Therapy in Resectable Non-Small-Cell Lung Cancer J. Clin. Oncol., April 15, 2002; 20(8): 1989 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Vaporciyan, K. W. Merriman, F. Ece, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. C. Nesbitt, and J. B. Putnam Jr Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation Ann. Thorac. Surg., February 1, 2002; 73(2): 420 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Novoa, G. Varela, and M.F. Jimenez Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 700 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doddoli, P. Thomas, X. Thirion, Y. Seree, R. Giudicelli, and P. Fuentes Postoperative complications in relation with induction therapy for lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 385 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Siegenthaler, K. M. Pisters, K. W. Merriman, J. A. Roth, S. G. Swisher, G. L. Walsh, A. A. Vaporciyan, W. R. Smythe, and J. B. Putnam Jr Preoperative chemotherapy for lung cancer does not increase surgical morbidity Ann. Thorac. Surg., April 1, 2001; 71(4): 1105 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bueno, W. G. Richards, S. J. Swanson, M. T. Jaklitsch, J. M. Lukanich, S. J. Mentzer, and D. J. Sugarbaker Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann. Thorac. Surg., December 1, 2000; 70(6): 1826 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sonobe, M. Nakagawa, M. Ichinose, N. Ikegami, M. Nagasawa, and T. Shindo Analysis of risk factors in bronchopleural fistula after pulmonary resection for primary lung cancer Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 519 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Strauss Role of Chemotherapy in Stages I to III Non-small Cell Lung Cancer* Chest, December 1, 1999; 116(suppl_3): 509S - 516S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Sonett, M. J. Krasna, M. Suntharalingam, J. Schuetz, L. A. Doyle, R. Lilenbaum, and Z. Gamliel Safe pulmonary resection after chemotherapy and high-dose thoracic radiation Ann. Thorac. Surg., August 1, 1999; 68(2): 316 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna, C. E. Reed, W. C. Nugent, J. Olak, D. J. Sugarbaker, M. R. Green, and L. J. Kohman Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach Ann. Thorac. Surg., July 1, 1999; 68(1): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, and M. Demedts Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rendina, F. Venuta, T. De Giacomo, I. Flaishman, P. Fazi, C. Ricci, Sponsor:, and V. W. Rusch SAFETY AND EFFICACY OF BRONCHOVASCULAR RECONSTRUCTION AFTER INDUCTION CHEMOTHERAPY FOR LUNG CANCER J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 830 - 837. [Abstract] [Full Text]
|
|
|
|
|
|
T. De Giacomo, E. A. Rendina, F. Venuta, G. D. Rocca, and C. Ricci Thoracoscopic Staging of IIIB Non-Small Cell Lung Cancer Before Neoadjuvant Therapy Ann. Thorac. Surg., November 1, 1997; 64(5): 1409 - 1411. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Mathisen, J. C. Wain, C. Wright, N. Choi, R. Carey, A. Hilgenberg, M. Grossbard, T. Lynch, and H. Grillo ASSESSMENT OF PREOPERATIVE ACCELERATED RADIOTHERAPY AND CHEMOTHERAPY IN STAGE IIIA (N2) NON-SMALL-CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 123 - 133. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
